Samuli Ripatti, PhD, is the Director of the Institute for Molecular Medicine Finland (FIMM), a professor of Biometry at the Faculty of Medicine (UH) and a Scholar at the Broad Institute of MIT and Harvard in Cambridge, MA, USA. He is also the director of the Academy of Finland Centre of Excellence in Complex Disease Genetics. His research group studies genetic variation in the Finnish population and its effects on common complex disease risks and management. His research focuses in particular on cardiometabolic diseases as models to learn about disease mechanisms and genomic strategies for diagnoses and prevention. He has published over 250 articles that have been cited over 26,000 times. He is also currently chairing Doctoral Programmes in Biomedicine and Population Health.
Project coordinator, GeneRisk & KardioKompassi®
Doctoral candidate
Aki S. Havulinna, DSc (Tech.), Adjunct professor, is a Senior Researcher at the Ripatti group. Originally trained as a chemical engineer, he has worked as a statistician throughout his professional career. His work has focused on genetic and other risk factors and risk prediction of chronic diseases, especially cardiovascular diseases. At FIMM he co-leads the FinnGen clinical team, creating a vast range of disease endpoints based on nationwide health register data. He is currently a joint researcher at FIMM and at the National Institute for Health and Welfare (THL) where he has worked as a statistician since 2004. He is now leading there a study group working with the FINRISK metagenomics project. He has published over 160 scientific articles which have been cited over 11000 times.
Doctoral candidate
Bioinformatician, doctoral candidate, Project Manager, "Personalized disease risk platform"
Post doctoral researcher
Doctoral candidate
Post doctoral researcher
Doctoral candidate
Post doctoral researcher
Doctoral researcher